Vaccination for meningococcal disease
Vaccines are available against serogroups A, B, C, Y and W. Most instances of the disease in Europe are caused by serogroups B and C.
Vaccine safety and effectiveness
This document provides an overview of the two meningococcal B vaccines evaluated by the European Medicines Agency (EMA) to prevent invasive meningococcal disease (IMD) caused by Neisseria meningitidis group B. It also explains the scientific evidence supporting the vaccines’ safety and effectiveness. It aims to support healthcare professionals’ discussions with parents and carers.
Immunisation & childhood vaccination
